Plantar fibromatosis, also known as Ledderhose disease, is a rare condition characterized by the thickening of connective tissue in the soles of the feet. This can lead to the formation of nodules, causing discomfort and difficulty in walking. While the exact cause remains unclear, it is often linked to genetic predisposition or repetitive trauma to the foot.
This clinical trial assesses the safety, efficacy, and tolerability of a study drug compared to a placebo for the treatment of Plantar Fibromatosis. Participants will help evaluate a promising investigational therapy, contributing to advancements in care for this challenging condition.
